Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
465 hedge funds and large institutions have $7.55B invested in Abiomed Inc in 2019 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 151 increasing their positions, 160 reducing their positions, and 53 closing their positions.
58% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 53
5% more funds holding
Funds holding: 443 → 465 (+22)
2% more capital invested
Capital invested by funds: $7.39B → $7.55B (+$165M)
6% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 160
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
61% less call options, than puts
Call options by funds: $111M | Put options by funds: $283M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$330M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$92.7M |
| 3 |
BlackRock
New York
|
+$71.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$67.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$65.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$86.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$70.8M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$52.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$34.5M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$33.4M |
ABMD Hedge Fund Activity: Q4 2019 in Review
465 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2019, worth a combined $7.55B — up 2.2% from $7.39B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new ABMD positions and 53 closed out — a net gain of 31 holders — while 151 added to existing stakes and 160 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $330M. The largest seller was Artisan Partners, exiting entirely with an estimated $86.4M sold.
- 465 institutional investors held Abiomed Inc (ABMD) as of Q4 2019, up from 443 in Q3 2019.
- Funds reported $7.55B of Abiomed Inc stock for Q4 2019, up 2.2% quarter-over-quarter.
- 84 funds opened new Abiomed Inc positions in Q4 2019 and 53 closed out, a net change of +31 holders.
- The largest Abiomed Inc buyer in Q4 2019 was Wellington Management Group, an estimated $330M added.
- The largest Abiomed Inc seller in Q4 2019 was Artisan Partners, an estimated $86.4M sold.
Based on aggregated 13F filings for Q4 2019.